Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.66 |
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23200434 | 1.00 | ALDH1A1 (0.66) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL28093510 | 0.98 | ALDH1A1 (0.62) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL7771166 | 0.91 | ALDH1A1 (0.53) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL15566 | 0.89 | TSHR (0.50) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL29912563 | 0.89 | TSHR (0.50) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL15380707 | 0.89 | TSHR (0.50) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL491650 | 0.89 | TSHR (0.50) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL8752681 | 0.89 | TSHR (0.50) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL20564136 | 0.89 | TSHR (0.50) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL8752652 | 0.89 | TSHR (0.50) | ALDH1A1LMNAMAPTABCC4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 439 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117050229-B | Emulsion type alumina red mud sedimentation flocculant and preparation method thereof | 矿冶科技集团有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117050229-A | Emulsion type alumina red mud sedimentation flocculant and preparation method thereof | 矿冶科技集团有限公司 | 2023-11-14 | — | — | CN | claimed |
| CN-115850834-B | High-performance polyethylene/nano silicon dioxide composite cable insulating resin and preparation method and application thereof | 南通大学 | 2023-06-27 | — | — | CN | claimed |
| CN-115850834-A | High-performance polyethylene/nano silicon dioxide composite cable insulating resin and preparation method and application thereof | 南通大学 | 2023-03-28 | — | — | CN | claimed |
| JP-1316388-A | — | — | None | — | — | JP | disclosed |
| JP-9059357-A | — | — | None | — | — | JP | disclosed |
| US-12637527-B2 | Method of producing fluoropolymer | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-26 | — | — | US | disclosed |
| WO-2026105786-A1 | FLUORINE-CONTAINING CROSSLINKED BODY AND METHOD FOR PRODUCING SAME, AND LAMINATE AND METHOD FOR MANUFACTURING SAME | ＡＧＣ株式会社 | 2026-05-21 | — | — | WO | disclosed |
| CN-122037043-A | Tube and method for manufacturing the same | 大金工业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-116897174-B | Fluorine-containing copolymer | 大金工业株式会社 | 2026-05-12 | — | — | CN | disclosed |
| CN-116888171-B | Fluorine-containing copolymer | 大金工业株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-12612477-B2 | Method for producing fluoropolymer, polytetrafluoroethylene composition, and polytetrafluoroethylene powder | DAIKIN INDUSTRIES, LTD. (JP) | 2026-04-28 | — | — | US | disclosed |
| EP-1359164-A1 | PROCESS FOR PRODUCING FLUOROPOLYMERS | Daikin Industries, Ltd. (JP) | 2003-11-05 | — | — | EP | disclosed |
| US-5616608-A | Method of treating atherosclerosis or restenosis using microtubule stabilizing agent | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-04-01 | — | — | US | disclosed |
| JP-H0959357-A | PRODUCTION OF TERMINAL-MODIFIED POLYESTER BY ENZYME CATALYZED POLYMERIZATION | NAGASE & CO LTD | 1997-03-04 | — | — | JP | disclosed |
| US-5000881-A | Polymerizable organosilane compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1991-03-19 | — | — | US | disclosed |
| US-5000881-A | Polymerizable organosilane compound | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1991-03-19 | — | — | US | disclosed |
| JP-H01316388-A | POLYMERIZABLE SILANE COMPOUND | SHIN ETSU CHEM CO LTD | 1989-12-21 | — | — | JP | disclosed |
| US-4135045-A | PROCESS FOR POLYMERIZATION OF OLEFINS AND CATALYST COMPOSITION THEREFOR | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-01-16 | — | — | US | disclosed |
| US-4048415-A | TITANIUM-ALUMINUM COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637527-B2 | Method of producing fluoropolymer | FGB, MSR1, CBR1 | ALDH1A1 4407/4885LMNA 1439/4885MAPT 2378/4885 |
| US-12612477-B2 | Method for producing fluoropolymer, polytetrafluoroethylene composition, and polytetrafluoroethylene powder | CFAP410, CFAP20, PFN1 | ALDH1A1 2366/4885LMNA 4859/4885MAPT 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.